Brett Fishbin

Stock Analyst at KeyBanc

(0.86)
# 4,022
Out of 5,022 analysts
123
Total ratings
43.4%
Success rate
-2.6%
Average return

Stocks Rated by Brett Fishbin

NeuroPace
Sep 17, 2026
Initiated Coverage: Buy
Price Target: $18
Current: $13.15
Upside: +36.88%
The Cooper Companies
Sep 10, 2026
Reiterated: Hold
Price Target: n/a
Current: $57.41
Upside: -
ResMed
Aug 31, 2026
Reiterated: Buy
Price Target: $255 → $267
Current: $221.15
Upside: +20.73%
STERIS
Aug 17, 2026
Reiterated: Buy
Price Target: $269
Current: $209.34
Upside: +28.50%
Solventum
Aug 6, 2026
Reiterated: Buy
Price Target: $102
Current: $87.77
Upside: +16.21%
LeMaitre Vascular
Aug 5, 2026
Reiterated: Hold
Price Target: n/a
Current: $80.19
Upside: -
Inspire Medical Systems
Aug 4, 2026
Reiterated: Hold
Price Target: n/a
Current: $70.78
Upside: -
Integer Holdings
Aug 3, 2026
Downgraded: Hold
Price Target: n/a
Current: $126.42
Upside: -
Kimball Electronics
Jul 2, 2026
Initiated Coverage: Hold
Price Target: n/a
Current: $28.31
Upside: -
LivaNova
Jun 22, 2026
Rated: Buy
Price Target: $81 → $92
Current: $74.70
Upside: +23.16%
Reiterated: Buy
Price Target: CHF 75.89 → CHF 73.39
Current: CHF 52.86
Upside: +38.84%
Reiterated: Buy
Price Target: $164
Current: $157.12
Upside: +4.38%
Reiterated: Hold
Price Target: n/a
Current: $18.12
Upside: -
Reiterated: Hold
Price Target: n/a
Current: $294.99
Upside: n/a